These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23388602)

  • 1. [The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12 Pt 2):20-30. PubMed ID: 23388602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of cavinton in the treatment of patients with chronic blood flow insufficiency. Russian multicenter clinical-epidemiological program "CALIPSO"].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):49-52. PubMed ID: 21311488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possibilities of cavinton therapy regimen for infusions and cavinton comforte in acute and early recovery periods after ischemic stroke].
    Belova LA; Mashin VV; Proshin AN; Ovsyannicova AN; Kostishko BB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):51-58. PubMed ID: 29053121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A multicenter program on assessment of efficacy and safety of a new therapeutic scheme for patients with chronic cerebrovascular insufficiency].
    Skoromets AA; Tanashian MM; Chukanova EI; Petrova EA; Spirin NN; Nikonov AA; Peverennova IE; Levin IaI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5 Suppl 2):44-8. PubMed ID: 19894300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of cavinton in patients with lacunar stroke developed against the background of diabetes mellitus and arterial hypertension].
    Spirin NN; Pizova NV; Shadrichev VA; Filatov VF; Bakucheva MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(4):64-6. PubMed ID: 18688926
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cavinton forte treatment of cerebral vascular insufficiency in patients with coronary heart disease and arterial hypertension].
    Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(7):31-4. PubMed ID: 16921716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cavinton on the hemorheological parameters of chronic cerebrovascular patients].
    Sapary L; Horvath B; Alexy T; Marton Z; Kesmarky G; Zsots M; Nagy F; Czopf I; Toth K
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):47-51. PubMed ID: 16841484
    [No Abstract]   [Full Text] [Related]  

  • 9. [Positron-emission tomography in the diagnosis of middle cerebral artery lesions].
    Prakhova LN; Il'ves AG; Kataeva GV; Pozdniakov AV; Stoliarov ID
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12 Suppl 2):35-40. PubMed ID: 20879103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The results of clinical study of cavinton efficacy inpatients with chronic brain ischemia].
    Doronin BM; Popova TF; Kornach NV; Klimova LA; Volkova II; Chelysheva LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):48-50. PubMed ID: 19253466
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment].
    Gavrilova SI; Kolykhalov IV; Fedorova IaB; Selezneva ND; Kalyn IaB; Roshchina IF; Odinak MM; Emelin AIu; Kashin AV; Gustov AV; Antipenko EA; Korshunova IuA; Davydova TA; Messler G
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(1):62-9. PubMed ID: 20436440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The results of the multicenter observational program "GLOBUS" on the study of the prevalence of vertigo and treatment schemes in outpatient clinics].
    Putilina MV; Baranova OA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(5):33-8. PubMed ID: 24988956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cavinton in the treatment of ischemic cerebral stroke. Clinical and computerized-tomographic evaluation].
    Domzał T; Kozłowski P; Zaleska B
    Neurol Neurochir Pol; 1986; 20(3):234-40. PubMed ID: 3537828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The safe use of cavinton forte in discirculatory encephalopathy].
    Protasov KV; Dzizinskiĭ AA; Shprakh VV; Sinkevich DA; Kuklin SG; Filatova LN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):55-7. PubMed ID: 16548377
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of cavinton in neuropaediatrics].
    Studenikin VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):63-4. PubMed ID: 15847328
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cavinton administration in hypertensive encephalopathy].
    Putilina MV; Grishin DV
    Ter Arkh; 2008; 80(12):73-8. PubMed ID: 19227913
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cavinton in the complex treatment of patients with chronic cerebrovascular insufficiency].
    Chukanova EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(9):35-9. PubMed ID: 19770831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Cavinton drip infusion in ophthalmology. II. Effect of Cavinton drip infusion in eye diseases caused by vascular occlusion or stenosis.
    Imre G
    Ther Hung; 1986; 34(2):84-6. PubMed ID: 3449973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke].
    Martynov MIu; Boĭko AN; Kamchatnov PR; Kabanov AA; Iasamanova AN; Shchukin IA; Kolesnikova TI; Chubykin VI; Glukhareva AP; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 2):21-6. PubMed ID: 22677765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.